Unusual manifestations of tegumentary leishmaniasis in AIDS patients from the New World

British Journal of Dermatology

Volumn 160, Issue 2, 2009, Pages 311-318

  Lindoso, J A L ^a,b   Barbosa, R N ^a   Posada Vergara, M P ^a   Duarte, M I S ^a   Oyafuso, L K ^b   Amato, V S ^a   Goto, H ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS   (Brazil)

Author keywords

AIDS; Clinical presentation; Highly active antiretroviral therapy; New World; Tegumentary leishmaniasis

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIPROTOZOAL AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AMASTIGOTE; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; DEMOGRAPHY; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LEISHMANIA; MALE; MEDICAL RECORD; PARAMETER; PRIORITY JOURNAL; RECURRENT DISEASE; SKIN LEISHMANIASIS; SKIN TEST; TREATMENT OUTCOME;

EID: 58349092306     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08908.x     Document Type: Article

References (48)

1. Desjeux P, Alvar J. Leishmania/HIV co-infections: epidemiology in Europe. Ann Trop Med Parasitol 2003 97 (Suppl. 1 3 15.
2. Puig L, Pradinaud R. Leishmania and HIV co-infection: dermatological manifestations. Ann Trop Med Parasitol 2003 97 (Suppl. 1 107 14.
3. Brazil, Ministry of Health. Secretaria de Vigilância em Saúde - SVS. Available at: http://www.saude.gov.br/svs (last accessed 10 October 2007).
4. Brazil, Ministry of Health. National STD/AIDS Programme Epidemiological Data. Available at: http://www.aids.gov.br (last accessed 10 October 2007).
5. Coura JR, Galvão-Castro B, Grimaldi G. Disseminated American cutaneous leishmaniasis in a patient with AIDS. Mem Inst Oswaldo Cruz 1987 82 : 581 2.
6. Machado ES, Braga MP, Da Cruz AM et al. Disseminated American muco-cutaneous leishmaniasis caused by Leishmania braziliensis in a patient with AIDS: a case report. Mem Inst Oswaldo Cruz 1992 87 : 487 92.
7. Mattos M, Caiza A, Fernandes O et al. American cutaneous leishmaniasis associated with HIV infection: report of four cases. J Eur Acad Dermatol Venereol 1998 10 : 218 25.
8. Sampaio RNR, Salaro CP, Resende P, de Paula CDR. American cutaneous leishmaniasis associated with HIV/AIDS: report of four clinical cases. Rev Soc Bras Med Trop 2002 35 : 651 4.
9. Rabello A, Orsini M, Disch J. Leishmania/HIV co-infection in Brazil: an appraisal. Ann Trop Med Parasitol 2003 97 (Suppl. 1 17 28.
10. Rosatelli JB, Souza CS, Soares FA et al. Generalized cutaneous leishmaniasis in acquired immunodeficiency syndrome. J Eur Acad Dermatol Venereol 1998 10 : 229 32.
11. Souza IS, Naiff RD, Guimarães TC et al. American cutaneous leishmaniasis due to Leishmania (Viannia) guyanensis as an initial clinical presentation of human immunodeficiency virus infection. J Eur Acad Dermatol Venereol 1998 10 : 214 7.
12. Borges AS, Machado AA, Ferreira MS et al. Concomitância de leishmanioses e infecção pelo vírus da imunodeficiê ncia humana (HIV): estudo de quatro casos. Rev Soc Bras Med Trop 1999 32 : 713 19.
13. Da Cruz AM, Filgueiras DV, Coutinho Z et al. Atypical mucocutaneous leishmaniasis caused by Leishmania braziliensis in an acquired immunodeficiency syndrome patient: T-cell responses and remission of lesions associated with antigen immunotherapy. Mem Inst Oswaldo Cruz 1999 94 : 537 42.
14. Couppie P, Clyti E, Sobesky M et al. Comparative study of cutaneous leishmaniasis in human immunodeficiency virus (HIV)-infected patients and non-HIV-infected patients in French Guiana. Br J Dermatol 2004 151 : 1165 71.
15. Niamba P, Goumbri-Lompo O, Traoré A et al. Diffuse cutaneous leishmaniasis in an HIV-positive patient in western Africa. Australas J Dermatol 2007 48 : 32 4.
16. Calza L, D'Antuono A, Marinacci G et al. Disseminated cutaneous leishmaniasis after visceral disease in a patient with AIDS. J Am Acad Dermatol 2004 50 : 461 5.
17. Couppie P, Clyti E, Sainte-Marie D et al. Disseminated cutaneous leishmaniasis due to Leishmania guyanensis. Case of a patient with 425 lesions. Am J Trop Med Hyg 2004 71 : 558 60.
18. Rios-Buceta L, Buezo GF, Penas PF et al. Post-kala-azar dermal leishmaniasis in an HIV-patient. Int J Dermatol 1996 35 : 303 4.
19. Bittencourt A, Silva N, Straatmann A et al. Post-kala-azar dermal leishmaniasis associated with AIDS. Braz J Infect Dis 2002 6 : 313 16.
20. Costa FA, Goto H, Saldanha LC et al. Histopathologic patterns of nephropathy in naturally acquired canine visceral leishmaniasis. Vet Pathol 2003 40 : 677 84.
21. Colebunders R, Depraetere K, Verstraeten T et al. Unusual cutaneous lesions in two patients with visceral leishmaniasis and HIV infection. J Am Acad Dermatol 1999 41 : 847 50.
22. Postigo C, Llamas R, Zarco C et al. Cutaneous lesions in patients with visceral leishmaniasis and HIV infection. J Infect 1997 35 : 265 8.
23. Alvar J, Canavate C, Gutierrez-Solar B et al. Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin Microbiol Rev 1997 10 : 298 319.
24. Pérez C, Solías Y, Rodríguez G. Diffuse cutaneous leishmaniasis in a patient with AIDS. Biomedica 2006 26 : 485 97.
25. Ndiaye PB, Develoux M, Dieng MT, Huerre M. Diffuse cutaneous leishmaniasis and acquired immunodeficiency syndrome in a Senegalese patient. Bull Soc Pathol Exot 1996 89 : 282 6.
26. Bañuls J, Boix V, Portilla J, Silvestre JF. Leishmaniasis as a cause of oral disease in HIV infection. AIDS 1995 9 : 96 8.
27. Cabello I, Caraballo A, Millan Y. Leishmaniasis in the genital area. Rev Inst Med Trop Sao Paulo 2002 44 : 105 7.
28. Agostoni C, Migliorini D, Dorigoni N et al. Genital ulcer in an AIDS patient with disseminated leishmaniasis. Eur J Clin Microbiol Infect Dis 1998 17 : 813 14.
29. Aste N, Pau M, Aste N, Biggi P. Leishmaniasis of the prepuce. J Eur Acad Dermatol Venereol 2002 16 : 92 4.
30. Orsini M, Silva M, Luz ZMP et al. Identification of Leishmania chagasi from skin in Leishmania/HIV co-infection: a case report. Rev Soc Bras Med Trop 2002 35 : 259 62.
31. Silva ES, Pacheco RS, Gontijo CMF et al. Visceral leishmaniasis caused by Leishmania (Viannia) braziliensis in a patient infected with human immunodeficiency virus. Rev Soc Bras Med Trop 2002 44 : 145 9.
32. Soong L, Chang CH, Sun J et al. Role of CD4+ T cells in pathogenesis associated with Leishmania amazonensis infection. J Immunol 1997 158 : 5374 83.
33. Terabe M, Kuramochi T, Ito M et al. CD4(+) cells are indispensable for ulcer development in murine cutaneous leishmaniasis. Infect Immun 2000 68 : 4574 7.
34. Da Cruz AM, Machado ES, Menezes JA et al. Cellular and humoral immune responses of a patient with American cutaneous leishmaniasis and AIDS. Trans R Soc Trop Med Hyg 1992 86 : 511 12.
35. Posada-Vergara MP, Lindoso JA, Tolezano JE et al. Tegumentary leishmaniasis as a manifestation of immune reconstitution inflammatory syndrome in 2 patients with AIDS. J Infect Dis 2005 192 : 1819 22.
36. Alvar J, Jiménez MI. Could infected drug-users act as potential Leishmania infantum reservoirs? AIDS 1994 8 : 854.
37. Pineda JA, Macías J, Morillas F et al. Evidence of increased risk for Leishmania infantum infection among HIV-seronegative intravenous drug users from southern Spain. Eur J Clin Microbiol Infect Dis 2001 20 : 354 7.
38. Cruz I, Morales MA, Noguer I et al. Leishmania in discarded syringes from intravenous drug users. Lancet 2002 359 : 1124 5.
39. Gari-Toussaint M, Lelievre A, Marty P, Le Fichoux Y. Contribution of serological tests to the diagnosis of visceral leishmaniasis in patients infected with human immunodeficiency virus. Trans R Soc Trop Med Hyg 1994 88 : 301 2.
40. Medrano FJ, Canavate C, Leal M et al. The role of serology in the diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type 1. Am J Trop Med Hyg 1998 59 : 155 62.
41. Deniau M, Canavate C, Faraut-Gambarelli F, Marty P. The biological diagnosis of leishmaniasis in HIV-infected patients. Ann Trop Med Parasitol 2003 97 (Suppl. 1 115 33.
42. Lainson R, Shaw JJ, Silveira FT et al. The dermal leishmaniases of Brazil, with special reference to the ecoepidemiology of the disease in Amazonia. Mem Inst Oswaldo Cruz 1994 89 : 435 43.
43. Cupolillo E, Brahim LR, Toaldo CB et al. Genetic polymorphism and molecular epidemiology of Leishmania (Viannia) braziliensis from different hosts and geographic areas in Brazil. J Clin Microbiol 2003 41 : 3126 32.
44. Tojal da Silva AC, Cupolillo E, Volpini AC et al. Species diversity causing human cutaneous leishmaniasis in Rio Branco, state of Acre, Brazil. Trop Med Int Health 2006 11 : 1388 98.
45. Amato VS, Nicodemo AC, Amato JG et al. Mucocutaneous leishmaniasis associated with HIV infection treated successfully with liposomal amphotericin B (AmBisome). J Antimicrob Chemother 2000 46 : 341 2.
46. Del Giudice P, Mary-Krause M, Pradier C et al. French Hospital Database on HIV Clinical Epidemiologic Group. Impact of highly active antiretroviral therapy on the incidence of visceral leishmaniasis in a French cohort of patients infected with human immunodeficiency virus. J Infect Dis 2002 186 : 1366 70.
47. Russo R, Nigro L, Panarello G, Montineri A. Clinical survey of Leishmania/HIV co-infection in Catania, Italy: the impact of highly active antiretroviral therapy (HAART). Ann Trop Med Parasitol 2003 97 (Suppl. 1 149 55.
48. Mira JA, Corzo JE, Rivero A et al. Frequency of visceral leishmaniasis relapses in human immunodeficiency virus infected patients receiving highly active antiretroviral therapy. Am J Trop Med Hyg 2004 70 : 298 301.